Elena Murphy

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Emergency Department

Multiple Myeloma

Transforming Growth Factor

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J Driscoll
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nature communications 15 (1) (2024)
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J Driscoll
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nature communications 15 (1) (2024)
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J Driscoll
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nature communications 15 (1) (2024)
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J Driscoll
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nature communications 15 (1) (2024)